Answers are grounded in this paper and cite their sources.
LPEHR results in long and durable relief of symptoms and improvement in QOL with PR or SIS. There does not appear to be a higher rate of complications or side effects with biologic mesh, but its benefit in reducing HH recurrence diminishes at long-term follow-up (more than 5 years postoperatively) or earlier.
No takes yet. Share an insight, caveat, or question.
Oelschlager et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: